DINALYTIQS Trademark Publication for Opposition

ChangeBridge: Trademarks - Medical Services (Class 044)

Published March 25th, 2026

Detected March 26th, 2026

Summary

The USPTO has published the DINALYTIQS trademark application for opposition, covering a range of medical, biomedical, and pharmaceutical services, as well as software for data processing and research. The publication opens a period for third parties to oppose the trademark registration.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for DINALYTIQS, identified by TM79411049, for opposition. This publication means the application has passed initial examination and is now open to challenges from any party who believes they would be harmed by its registration. The trademark covers a broad scope of services including medical and veterinary services, hygienic care, medical consultancy, and provision of medical information. It also extends to software and hardware for data processing, storage, and analysis in the fields of gene therapies, EHT data, and general biomedical research and development.

This publication is a procedural step in the trademark registration process. While it does not impose new compliance obligations on regulated entities, it signifies that a new trademark is potentially entering the market in the medical and pharmaceutical technology space. Companies operating in these sectors should be aware of this publication as it may impact their own branding or intellectual property strategies. The opposition period, which begins upon publication, allows interested parties to file an opposition if they have grounds to do so. Failure to file an opposition within the designated period may result in the trademark proceeding to registration.

What to do next

Monitor trademark opposition period for TM79411049 if relevant to existing IP.
Review DINALYTIQS service descriptions for potential conflicts with existing trademarks.

Source document (simplified)

← USPTO Trademark Applications

DINALYTIQS

Published for Opposition TM79411049 Kind: published Mar 25, 2026

Abstract

Medical services; biomedical services, namely, human tissue bank services; veterinary services; hygienic care for human beings and animals; medical consultancy and information services relating to medical, biomedical, veterinary and pharmaceutical products; provision of medical information relating to the preparation and dispensing of medicines; medical examination; Recorded or downloadable computer software and software platforms for data processing, storage and analysis for the development of gene therapies; recorded or downloadable computer software and software platforms for use in medical, biomedical, veterinary and pharmaceutical research and development; scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching apparatus and instruments in the nature of high speed cameras, electric sensors and electric actuators, optical filters, and photomultiplier tubes for use in medical, biomedical, veterinary and pharmaceutical research and development; computers and data processing equipment intended for use in medical, biomedical, veterinary and pharmaceutical research and development; downloadable or recorded software for database management, research and data analysis, particularly in the field of Engineered Heart Tissue (EHT) data; downloadable or recorded software for creating searchable databases; downloadable or recorded software for database management; Updating and maintenance of data in computer databases; compilation and systematization of information into computer databases; data processing services; all the aforementioned services in the field of medical, biomedical, veterinary and pharmaceutical research and development; Software development and programming of software and computer software platforms for others for use in medical, biomedical, veterinary and pharmaceutical research and development; computer platform as a service (PAAS) featuring computer software for data processing, data storage, and analysis for use in medical, biomedical, veterinary and pharmaceutical research and development; stem cell research services; consulting services relating to medical, biomedical, veterinary and pharmaceutical research and development; research relating to medical, biomedical, veterinary and pharmaceutical research and development; provision of information and data relating to medical, biomedical, veterinary and pharmaceutical research and development; biological research and analysis, namely, analysis of human tissue for medical, biomedical, veterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; scientific research services for others with respect to the isolation and cultivation of human cells and tissues; programming of computer software for others for information platforms on the Internet for use in medical, biomedical, veterinary and pharmaceutical research and development; rental of scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching apparatus and instruments, namely, rental of laboratory apparatus and instruments for use in medical, biomedical, veterinary and pharmaceutical research and development; rental of computer hardware and data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development; design, development and maintenance of computer software for database management; providing temporary use of online non-downloadable software for database management; database as a service (DBAAS), namely, cloud hosting of computer databases for others; computer data retrieval services, namely, data recovery services in the field of Engineered Heart Tissue (EHT) data; consulting services in the field of scientific analysis related to human tissue and Engineered Heart Tissue (EHT) data; softw...